Cargando…

The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C

BACKGROUND : the role of hepatitis C virus in the pathogenesis of atherosclerotic disease has been suggested by several studies. We aimed to assess the association between subclinical carotid atherosclerosis and chronic hepatitis C . METHODS: 40 patients infected with chronic hepatitis C and 40 cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Medhioub, Mouna, Bouzaidi, Khaled, Bachali, Asma, Khsiba, Amal, Hamzaoui, Lamine, Azouz, Mohamed Moussadek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Societe Tunisienne Des Sciences Medicales 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734473/
https://www.ncbi.nlm.nih.gov/pubmed/35244930
_version_ 1784628026588266496
author Medhioub, Mouna
Bouzaidi, Khaled
Bachali, Asma
Khsiba, Amal
Hamzaoui, Lamine
Azouz, Mohamed Moussadek
author_facet Medhioub, Mouna
Bouzaidi, Khaled
Bachali, Asma
Khsiba, Amal
Hamzaoui, Lamine
Azouz, Mohamed Moussadek
author_sort Medhioub, Mouna
collection PubMed
description BACKGROUND : the role of hepatitis C virus in the pathogenesis of atherosclerotic disease has been suggested by several studies. We aimed to assess the association between subclinical carotid atherosclerosis and chronic hepatitis C . METHODS: 40 patients infected with chronic hepatitis C and 40 contol cases were evaluated by anthropometric and metabolic measurements .The risk of subclinical atherosclerosis was assessed by ultrasound measurement of carotid intima-media thickness . A high cardiovascular risk atherosclerosis was defined by carotid intima-media thickness > 75th percentile. RESULTS: The carotid intima-media thickness and the prevalence of high cardiovascular risk atherosclerosis were significantly higher in the group infected with hepatitis C compared to the control group (0.68 VS 0.60, p = 0.02) and ( 82.5% vs. 40%; 0.001) respectively. In multivariate studies, activity ≥ A2 and age> 40 years were the independent factors associated with the carotid intima-media thickness and hepatitis C was the only independent factor associated with high cardiovascular risk atherosclerosis (OR = 4.81 CI at 95%: 1.6-14.42). CONCLUSION: In our study , chronic hepatitic C was associated with a high risk of carotid atherosclerosis .
format Online
Article
Text
id pubmed-8734473
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Societe Tunisienne Des Sciences Medicales
record_format MEDLINE/PubMed
spelling pubmed-87344732022-01-19 The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C Medhioub, Mouna Bouzaidi, Khaled Bachali, Asma Khsiba, Amal Hamzaoui, Lamine Azouz, Mohamed Moussadek Tunis Med Article BACKGROUND : the role of hepatitis C virus in the pathogenesis of atherosclerotic disease has been suggested by several studies. We aimed to assess the association between subclinical carotid atherosclerosis and chronic hepatitis C . METHODS: 40 patients infected with chronic hepatitis C and 40 contol cases were evaluated by anthropometric and metabolic measurements .The risk of subclinical atherosclerosis was assessed by ultrasound measurement of carotid intima-media thickness . A high cardiovascular risk atherosclerosis was defined by carotid intima-media thickness > 75th percentile. RESULTS: The carotid intima-media thickness and the prevalence of high cardiovascular risk atherosclerosis were significantly higher in the group infected with hepatitis C compared to the control group (0.68 VS 0.60, p = 0.02) and ( 82.5% vs. 40%; 0.001) respectively. In multivariate studies, activity ≥ A2 and age> 40 years were the independent factors associated with the carotid intima-media thickness and hepatitis C was the only independent factor associated with high cardiovascular risk atherosclerosis (OR = 4.81 CI at 95%: 1.6-14.42). CONCLUSION: In our study , chronic hepatitic C was associated with a high risk of carotid atherosclerosis . Societe Tunisienne Des Sciences Medicales 2021-04 2021-04-01 /pmc/articles/PMC8734473/ /pubmed/35244930 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Article
Medhioub, Mouna
Bouzaidi, Khaled
Bachali, Asma
Khsiba, Amal
Hamzaoui, Lamine
Azouz, Mohamed Moussadek
The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C
title The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C
title_full The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C
title_fullStr The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C
title_full_unstemmed The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C
title_short The risk of subclinical carotidatherosclerosis in patients with chronic hepatitis C
title_sort risk of subclinical carotidatherosclerosis in patients with chronic hepatitis c
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734473/
https://www.ncbi.nlm.nih.gov/pubmed/35244930
work_keys_str_mv AT medhioubmouna theriskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT bouzaidikhaled theriskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT bachaliasma theriskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT khsibaamal theriskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT hamzaouilamine theriskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT azouzmohamedmoussadek theriskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT medhioubmouna riskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT bouzaidikhaled riskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT bachaliasma riskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT khsibaamal riskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT hamzaouilamine riskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc
AT azouzmohamedmoussadek riskofsubclinicalcarotidatherosclerosisinpatientswithchronichepatitisc